Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary intracranial sarcomas in Peruvian children: a high-incidence clinicopathological series from a National Reference Center.

Ecancermedicalscience·2026
Same author

Stratification by Ki-67 Labeling Index Increases Specificity of p16<sup>INK4a</sup> Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Prospective Genomic Profiling of Consecutive Meningiomas.

JAMA oncology·2026
Same author

Laser insterstitial thermal therapy followed by craniotomy for tumor resection for pediatric diffuse midline glioma: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Alpha-B-crystallin immunohistochemistry: A sensitive but non-specific marker for epileptogenic lesions.

Brain pathology (Zurich, Switzerland)·2026

Related Experiment Video

Updated: Mar 24, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.4K

Histologic classification of gliomas.

Arie Perry1, Pieter Wesseling2

  • 1Departments of Pathology and Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.

Handbook of Clinical Neurology
|March 8, 2016
PubMed
Summary

This chapter reviews glial tumors, including diffuse gliomas like astrocytomas and oligodendrogliomas, and nondiffuse types. It highlights the integration of molecular data with histology for more accurate classification of central nervous system (CNS) neoplasms.

Keywords:
astrocytomaependymomaglioblastomagliomaglioneuronal tumorhistopathologyimmunohistochemistrymolecular diagnosticsneuropathologyoligodendroglioma

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K
A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
08:35

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs

Published on: July 20, 2017

13.8K

Related Experiment Videos

Last Updated: Mar 24, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.4K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K
A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
08:35

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs

Published on: July 20, 2017

13.8K

Area of Science:

  • Neuro-oncology
  • Central Nervous System (CNS) Tumors
  • Histopathology

Background:

  • Gliomas are a diverse group of CNS tumors traditionally classified by histology and grade.
  • Diffuse gliomas infiltrate CNS parenchyma and include astrocytic, oligodendroglial, and mixed types (WHO grades II-IV).
  • Nondiffuse gliomas, such as pilocytic astrocytomas and ependymal tumors (WHO grades I-III), exhibit circumscribed growth.

Purpose of the Study:

  • To provide a comprehensive overview of glial neoplasms according to the WHO 2016 classification.
  • To discuss both diffuse and less frequent nondiffuse gliomas, including mixed neuronal-glial tumors.
  • To emphasize the evolving role of molecular findings in glioma classification.

Main Methods:

  • Review of histological features of glial neoplasms.
  • Integration of World Health Organization (WHO) 2016 classification criteria.
  • Discussion of molecular underpinnings influencing tumor classification.

Main Results:

  • Histologic diagnosis has historically guided prognosis and treatment for gliomas.
  • Molecular information provides a more robust basis for classifying gliomas.
  • The WHO 2016 classification integrates both histologic and molecular findings.

Conclusions:

  • Accurate classification of gliomas relies on a combination of histology and molecular data.
  • Understanding glial tumor heterogeneity is crucial for effective management.
  • This chapter serves as a foundation for understanding glioma classification, complementing molecular insights.